Cancer
- About the area
- Groups
The area of cancer research has been structured into three different pillars: clinical research, translational laboratory research and innovation in cancer diagnosis and treatment.
Within the clinic, we can currently find four lines of research that have to do with the volume of incidence and prevalence of neoplastic disease, such as: breast cancer, lung cancer, urological tumors and gastrointestinal tumors. Each of them is made up of professionals who are dedicated to the diagnosis, treatment and follow-up of specific neoplasms.
In all lines there is extensive experience in conducting national and international studies. Many of the members belong to different national and international scientific societies, which allows them to be in touch with the latest scientific advances. Work is currently underway to increase the specific number of clinical research lines.
Within translational research, the goal has been set in the study at the cellular and molecular level of cancer with particular interest in the identification of new biomarkers that allow us to predict the survival of our cancer patients in their different types and stages, as well as adapting the treatment in a more personalized way. Work is also underway to increase cooperation with all those professionals who are researching into some type of cancer.
Finally, the cancer innovation group is investigating several strategic lines for the development of new diagnostic and treatment tools using new technologies with potential application in health.
Strategic lines of the area
- Research into new oncological therapies.
- Study of biomarkers involved in the prognosis and prediction of the effectiveness of oncological treatments.
- Search for new diagnostic tools based on artificial intelligence.
Group A1G4 - Biomedical research in cancer
Accreditation level: Consolidated group
The incidence of cancer is gradually increasing worldwide, as well as being one of the leading causes of death in our environment. The importance of having new knowledge about the behavior of the disease is a challenge of obvious relevance.
The Biomedical Research in Cancer group is a group with a long clinical research history. It is made up of professionals from different medical and surgical specialties, which allows us to tackle cancer research in a multidisciplinary and global way, addressing the prognostic, clinical and molecular factors of cancer, as well as developing new treatment options. Specifically, the group is working on the study of new drugs and therapies for breast, ovarian, head and neck, lung, digestive, and thyroid cancers.
The group participates with national and international companies and groups, such as SEOM, GEICAM, SOGUG, TTD, GEMCAD and EORTC, which allows the development of projects in a wide field with which results are achieved with a high degree of evidence.
Lines of research
- Research into new drugs and effective therapies in cancer patients.
- Study of biomarkers involved in the prognosis and prediction of treatment efficacy.
- Search for supportive treatment for cancer patients: palliative care and improvement of treatment side effects.
- Oncogeriatric assessment tools. Definition and evaluation of its effectiveness and its impact on patients' quality of life.
Composition of the group
Enrique Gallardo Diaz (Cap de grup)
Elsa Dalmau Pórtulas (co-cap de grup)
Doctoral research staff
- Bejarano González, Natalia
- Castañer González, Eva
- Fernández Morales, Luís Antonio
- Garcia Borobia, Francisco Javier
- Garcia Monforte, Neus
- Medarde Ferrer, Meritxell
- Muñoz Rodríguez, Jesús
- Papaleo, Natalia
- Querol Niñerola, Rosa
- Reques Llano, Armando
- Seguí Palmer, Miquel Àngel
Predoctoral
- Domínguez García, Arturo
- Hannaoui Hadi, Naim
- Vilaseca Creus, Xavier
Non-doctoral research staff
- Aparicio Rodríguez, Oscar
- Bonfill Abella, Teresa
- Llort Pursals, Gemma
- Medina Argení, Sandra
- Nogales Herranz, Sara
- Ribera Fernandez, Paula
- Ribot Luna, Laia
- Vila Martínez, Laia
Associated professionals
- Andreu Magarolas, Marta
- Barcons Vilaplana, Santi
- Cabrera Romero, José Manuel
- Gallardo Cistaré, Xavier
- Giner Joaquin, Júlia
- López Mestres, Aida
- Malet Munté, Antoni
- Nogueiras Pérez, Rosa
- Pérez Riverola, Víctor
- Prenafeta Moreno, Mario
- Puig Domingo, Jordi
- Ribot Berenguer, Teresa
Group A1G5 - Molecular and Translational Research in Cancer
Accreditation level: Popup group
2017 SGR 473
The Molecular and Translational Research Group on Cancer carries out several projects aimed at research at the cellular and molecular level of cancer with particular interest in the search for biomarkers for the diagnosis, prognosis and prediction of response to treatment.
The aim is that the results of this research can be transferred to clinical practice and be able to offer cancer patients a more personalized and appropriate treatment for each type of tumor.
The group is made up of postdoctoral and predoctoral researchers, mostly from the pathology department of our Hospital. It also has close internal and external collaborations with researchers from various prestigious groups, which allows a multidisciplinary approach to research projects.
Lines of research
- Clinicopathological and molecular characterization of thyroid cancer.
- Research into new biomarkers for the diagnosis and prognosis of colon cancer.
- Research in the genomics of lung cancer.
- Clinicopathological and molecular characterization of endometrial and ovarian carcinoma.
Composition of the group
M. Rosa Bella Cueto (Cap de grup) | ORCID
Adrià Asensi Puig (co-cap de grup) | ORCID
Doctoral research staff
- Costa Trachsel, Irmgard
- Ferreres Piñas John Carlos
Predoctoral
- Onieva Carbajo, Ricard
- Papaleo, Natalia
Non-doctoral research staff
- Aguirre Neira, Fabiana Inés
- Carreras Salas, Ruben
- Escoda Giralt, Maria Rosa
- Parra Parente, Tamara
- Piñol Ballus, David
- Reques Llano, Armando
Associated professionals
- Sáez Artacho, Empar